TP53 and cancer: A total of 39 high-frequency mutant genes showed significant differences in mutation rates among three macrophage-related subtypes, among which the mutation rate of TP53, the most common mutation gene in human cancer, was 26.49% in C1, 20.19% in C2, and 49.21% in C3.